I hope you are giving this info to a lawyer. Attorney Thomas Renz in Ohio, USA is a good one who has a lawsuit going with inaccurate PCR tests part of it.
the imperial link is about a study where they claim they gave people "sars-cov2" but it doesn't have a control group. what they gave them is a manufactured product. It says "the virus was isolated by inoculation of a qualified cGMP Vero cell line with the clinical sample", a "nose/throat swab" i.e. they made something and called it "the virus" rather than isolated 'a virus' from nature. Then:
" A seed virus stock was then generated by a further passage on the same cGMP Vero cell line. The seed virus stock was then used to manufacture the challenge virus in accordance with cGMP at the Zayed Centre for Research GMP manufacturing facility of Great Ormond Street Hospital, and a challenge virus master virus bank (MVB) was produced. Individual dose inoculum vials were then produced in accordance with cGMP by dilution of the cGMP MVB with sucrose diluent. "
This in no way represents something that would actually happen in normal life. The participants might been stressed by the belief they were being infected with a dangerous virus with symptoms that they had already been conditioned to expect. This could thus have caused a nocebo effect together with a reaction to the decaying proteins or 'live vaccine' whatever they were investingating etc..
Participants were "paid about £4,000 for their two to three-week stay" and shown pictures of people playing computer games, reading books, smiling at their clipboards etc. in corporate quarantine faciltites owned by the 'challenge virus' manufacturers. They were told it was to "develop vaccines" rather than establish if there was a virus:
I hope you are giving this info to a lawyer. Attorney Thomas Renz in Ohio, USA is a good one who has a lawsuit going with inaccurate PCR tests part of it.
the imperial link is about a study where they claim they gave people "sars-cov2" but it doesn't have a control group. what they gave them is a manufactured product. It says "the virus was isolated by inoculation of a qualified cGMP Vero cell line with the clinical sample", a "nose/throat swab" i.e. they made something and called it "the virus" rather than isolated 'a virus' from nature. Then:
" A seed virus stock was then generated by a further passage on the same cGMP Vero cell line. The seed virus stock was then used to manufacture the challenge virus in accordance with cGMP at the Zayed Centre for Research GMP manufacturing facility of Great Ormond Street Hospital, and a challenge virus master virus bank (MVB) was produced. Individual dose inoculum vials were then produced in accordance with cGMP by dilution of the cGMP MVB with sucrose diluent. "
This in no way represents something that would actually happen in normal life. The participants might been stressed by the belief they were being infected with a dangerous virus with symptoms that they had already been conditioned to expect. This could thus have caused a nocebo effect together with a reaction to the decaying proteins or 'live vaccine' whatever they were investingating etc..
Participants were "paid about £4,000 for their two to three-week stay" and shown pictures of people playing computer games, reading books, smiling at their clipboards etc. in corporate quarantine faciltites owned by the 'challenge virus' manufacturers. They were told it was to "develop vaccines" rather than establish if there was a virus: